APA

Carron C. P., Meyer D. M., Pegg J. A., Engleman V. W., Nickols M. A., Settle S. L., Westlin W. F., Ruminski P. G. & Nickols G. A. (19980602). A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. : Cancer research.

Chicago

Carron C P, Meyer D M, Pegg J A, Engleman V W, Nickols M A, Settle S L, Westlin W F, Ruminski P G and Nickols G A. 19980602. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. : Cancer research.

Harvard

Carron C. P., Meyer D. M., Pegg J. A., Engleman V. W., Nickols M. A., Settle S. L., Westlin W. F., Ruminski P. G. and Nickols G. A. (19980602). A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. : Cancer research.

MLA

Carron C P, Meyer D M, Pegg J A, Engleman V W, Nickols M A, Settle S L, Westlin W F, Ruminski P G and Nickols G A. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. : Cancer research. 19980602.